Lipoflex Peri (Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin)

The blend delivers a balanced profile of essential and non‑essential amino acids directly into the bloodstream, bypassing the gastrointestinal tract. These amino acids become immediately available for protein synthesis, help restore nitrogen balance, support tissue repair, and maintain metabolic stability during periods of increased protein breakdown.

The dose of Lipoflex Peri is individualized by the prescribing clinician based on the patient’s weight, metabolic needs, and clinical condition. Healthcare professionals calculate the required amino acid amount and infusion rate according to established nutrition guidelines and the patient’s laboratory parameters.

Safety data for Lipoflex Peri in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Lipoflex Peri, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Lipoflex Peri offers a comprehensive profile of ten amino acids designed for peri‑operative and catabolic support. Compared with single‑amino‑acid formulations, it provides a more balanced substrate for protein synthesis, potentially reducing the need for multiple infusions and simplifying nutritional management.

Lipoflex Peri must be stored at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze or shake the product. Before administration, allow the solution to reach room temperature if required, and inspect for particulate matter or discoloration.

Lipoflex Peri is administered intravenously, typically via a peripheral or central venous catheter. The infusion rate is set by the prescriber based on the patient’s nutritional plan and monitored continuously for tolerance, blood glucose, and electrolyte balance.

Serious risks include anaphylactic reactions, severe electrolyte disturbances, metabolic acidosis, and bacterial contamination if aseptic technique is compromised. Prompt recognition and management of these events are essential, and patients should be monitored closely during and after infusion.

Lipoflex Peri should be avoided in patients with known hypersensitivity to any of its amino acid components, those with uncontrolled hyperkalemia, severe renal impairment without appropriate dose adjustment, or in individuals where fluid overload poses a risk, such as uncontrolled heart failure.